Veronique Latger-Cannard
Overview
Explore the profile of Veronique Latger-Cannard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
757
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Laroye C, Thilly N, Gauthier M, Luc A, Latger-Cannard V, Eschwege V, et al.
Cytotherapy
. 2023 May;
25(8):877-884.
PMID: 37178096
Background Aims: Allogeneic hematopoietic stem cell transplantation (allo-SCT) is a curative treatment for chemo-resistant hematological malignancies. Because of transport restriction imposed by the coronavirus disease 2019 pandemic, regulatory bodies and...
2.
Schenone L, Notarantonio A, Latger-Cannard V, Fremeaux-Bacchi V, De Carvalho-Bittencourt M, Rubio M, et al.
World J Clin Cases
. 2022 Aug;
10(17):5702-5707.
PMID: 35979111
Background: Patients with paroxysmal nocturnal hemoglobinuria (PNH) have a clonal population of blood cells deficient in glycosylphosphatidylinositol-anchored (GPI-anchored) proteins, most of the time resulting from a mutation in the X-linked...
3.
Julien M, Latger-Cannard V, Salignac S, Aubert C, Gerard D, Broseus J, et al.
Ann Biol Clin (Paris)
. 2022 Jul;
80(3):252-258.
PMID: 35796473
Mature B-cell lymphoproliferation with hairy lymphocytes include Marginal Zone Splenic Lymphoma (SMZL), Hairy Cell Leukemia (HCL), Splenic Diffuse Red Pulp Lymphoma (SDRPL), and Variant Hairy Cell Leukemia (HCL-v), the two...
4.
Guisnel C, Lesesve J, Gerard D, Salignac S, Muller M, Feugier P, et al.
Ann Biol Clin (Paris)
. 2022 Feb;
80(1):47-54.
PMID: 35118947
Purpose: to report on the diagnostic and therapeutic management of LGLL investigated in the university hospital at Nancy, France. Methods: retrospective (7 years) collection of clinical and biological data and...
5.
Callet J, Latger-Cannard V, Gerard D, Salignac S, Granel-Brocard F, Campidelli A, et al.
Ann Biol Clin (Paris)
. 2021 Jun;
79(3):233-240.
PMID: 34165432
The Sezary syndrome has been defined by a triad combining erythrodermia, generalized lymphadenopathy, and the presence of circulating Sezary cells > 1 × 10/L characterized by a CD4+/CD8- phenotype with...
6.
Lesesve J, Latger-Cannard V, Mansuy L, Chastagner P, Broseus J
Pediatr Blood Cancer
. 2021 Mar;
68(8):e28999.
PMID: 33751771
No abstract available.
7.
Garnache-Ottou F, Vidal C, Biichle S, Renosi F, Poret E, Pagadoy M, et al.
Blood Adv
. 2019 Dec;
3(24):4238-4251.
PMID: 31869411
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia for which we developed a nationwide network to collect data from new cases diagnosed in France. In a...
8.
Manenq C, Lesesve J, Dreumont N, Massin F, Salignac S, Mansuy L, et al.
Int J Lab Hematol
. 2019 Dec;
42(1):52-60.
PMID: 31821742
Introduction: In the context of neuroblastoma (NB), the screening for bone marrow (BM) metastasis is a recurrent issue for hematology laboratory routine practice. Detection of low tumor burden using light...
9.
Solly F, Angelot-Delettre F, Ticchioni M, Genevieve F, Rambaud H, Baseggio L, et al.
Cytometry A
. 2019 Aug;
95(9):1008-1018.
PMID: 31364809
Flow cytometry is broadly used for the identification, characterization, and monitoring of hematological malignancies. However, the use of clinical flow cytometry is restricted by its lack of reproducibility across multiple...
10.
Decker J, Meyer S, Latger-Cannard V, Visanica S, Loppinet E, Lesesve J, et al.
Ann Biol Clin (Paris)
. 2017 Oct;
75(6):689-694.
PMID: 29043985
Mast cell leukemia is an extremely rare disease, which belongs to the systemic mastocytosis group (WHO 2016). We are reporting the case of a 79-year-old woman, without any hematological particular...